Results of the clinical and molecular-histological assessment of the effectiveness of the drug PROTEFLAZID® in the treatment of papilomavirus infection in women with cervical intraepithelial neoplasia
DOI:
https://doi.org/10.15574/HW.2024.4(173).514Keywords:
women, papillomavirus infection, cervical intraepithelial neoplasia, morphological studies, immunohistochemical studies, proteins p16 and Ki-67, PROTEFLAZID®Abstract
Aim — to evaluate the clinical and molecular-morphological effectiveness of the drug PROTEFLAZID® when used in the treatment of human papilloma virus (HPV) infection in women with a cytological koilocytic reaction, as well as in cervical epithelium combined with a mild degree of cervical intraepithelial neoplasia (CIN).
Materials and methods. Based on the results of the Pap test and HPV test, 90 women aged 20 to 35 years were involved in the study, who were divided into 3 groups: the group I (control) — 30 women with a negative HPV test and no CIN, the group II — 30 women with a positive HPV test without CIN, the group III — 30 women with CIN I on the background of HPV infection.
The article presents the results of a clinical and molecular-histological assessment of the effectiveness of the simultaneous use of oral and vaginal forms of the drug PROTEFLAZID® in the treatment of cervical HPV infection in women, which contributed to the eradication of HPV in 76.7–86.7% of cases, and in combined HPV-infections with cervical intraepithelial neoplasia of a mild degree (CIN I) — in 76.7% of patients until its persistent regression, which was due not only to the antiviral effect of PROTEFLAZID®, but also to its effect, as shown by the results of an immunohistochemical study, on the reduction of the expression of nuclear proteins p16 and Ki-67, which are reverse regulators of the cell cycle and significantly increase when cervical epithelial cells are affected by HPV.
Conclusions. The drug PROTEFLAZID® is currently one of the most effective drugs for the treatment of HPV infection, which can be recommended for the eradication of papillomaviruses in women with both low-risk cervical intraepithelial neoplasia (CIN I) and positive HPV-tests with a normal Pap test.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the author.
References
Allanson ER, Schmeler KM. (2021). Preventing Cervical Cancer Globally: Are We Making Progress? Cancer Prev Res (Phila). 14(12): 1055-1060. https://doi.org/10.1158/1940-6207.CAPR-21-0016
Bahriy̆ MM, Dibrova VA, Popadynets OH, Hryshchuk MI. (2016). Metodyky morfolohichnykh doslidzhen. Vinnytsia: Nova Knyha: 328.
Benyuk VO, Grinevich OI, Usevich IA, Sikachova IS, Shepetko MV. (2016). Therapeutic efficacy of Proteflazid, suppository among the patients with genitourinary viral-bacterial infection. Health of woman. 2(108): 162-166. https://doi.org/10.15574/HW.2016.108.162
Bogani G, Chiappa V, Pinelli C et al. (2020). Trends in prevalence in human papillomavirus types and their association with cervical dysplasia: an analysis on 15 138 women over 20 years. Eur. J. Cancer Prev. 29(5): 452-457. https://doi.org/10.1097/CEJ.0000000000000565
Godlevskaya NA, Starover AV. (2017). Clinical efficacy of topical use of vaginal suppositories Proteflazid® in the treatment of cervical intraepithelial neoplasia of mild and moderate degree caused by the human papilloma virus. Health of woman. 2(118): 55-60. https://doi.org/10.15574/HW.2017.118.55
Isidean SD, Wang Y, Mayrand MH et al. (2019). Assessing the time dependence of prognostic values of cytology and human papillomavirus testing in cervical cancer screening. Int. J. Cancer. 144(10): 2408-2418. https://doi.org/10.1002/ijc.31970
Kaminskyi VV, Shalko MH. (2016). Novi terapevtychni pidkhody do likuvannia zhinok z dysplaziieiu epiteliiu shyiky matky, zumovlenoiu papilomavirusnoiu infektsiieiu. Informatsiinyi lyst pro novovedennia v systemi okhorony zdorovia. K.: 49.
Kaminskyi VV, Shalko MH, Hrynevych OI. (2014). Proteflazid u vahitnykh: systemnyi ohliad rezultativ pisliareiestratsiinykh sposterezhen za bezpechnistiu ta efektyvnistiu zastosuvannia. Zdorovia zhinky. 6(92).
Kaminskyi VV, Shalko MH, Vorobiova LI ta insh. (2015). Proteflazid: spetsyfichna aktyvnist u doklinichnykh doslidzhenniakh; efektyvnist ta bezpechnist zastosuvannia u klinichnii praktytsi pry zakhvoriuvanniakh, sprychynenykh vyrusom papilomy liudyny (systematychnyi ohliad). Zdorovia zhinky. 3(99): 122-132.
Kravchuk IV. (2009). Ekspresiia markeriv r16, Ki67 ta r63 u zhinok iz tservikalnoiu patolohiieiu na tli infikuvannia virusom papilomy liudyny vysokoho kantserohennoho ryzyku. Zdorovia zhinky. 8(44): 233-216.
Lakatosh VP. (2006). Diahnostyka ta likuvannia tservikalnykh intraepitelialnykh neoplazii papilomavirusnoi etiolohii z vykorystanniam klinichnykh, tsytomorfolohichnykh, ultrastrukturnykh ta molekuliarno-biolohichnykh kryteriiv. Doktor. 5: 51-55.
MOZ Ukrainy. (2014). Unifikovanyi klinichnyi protokol pervychnoi, vtorynnoi (spetsializovanoi), tretynnoi (vysokospetsializovanoi) medychnoi dopomohy «Dysplaziia shyiky matky. Rak shyiky matky». Nakaz MOZ Ukrainy vid 02.04.2014 r. #236.
Ntanasis-Stathopoulos I, Kyriazoglou A, Liontos MA et al. (2020). Current trends in the management and prevention of human papillomavirus (HPV) infection. J. BUON, 25(3): 1281-1285.
Okunade KS. (2020). Human papillomavirus and cervical cancer. J. Obstet. Gynaecol. 40(5): 602-608. https://doi.org/10.1080/01443615.2019.1634030
Pitko VA, Huz IA, Demydenko OD ta insh. (2011). Papilomavirusna infektsiia: likuvannia ta profilaktyka. Tavriiskyi medyko-biolohichnyi visnyk. 14(3); 2 (55): 158-160.
Shponka OV. (2012). Diahnostyka, prohnoz ta likuvannia dysplazii shyiky matky, asotsiiovanoi z papilomavirusnoiu infektsiieiu u zhinok reproduktyvnoho viku. Dys. … k.med.n.
Shponka IS, Dorokhova OV, Shponka OV. (2005). Prohnostychne ta diahnostychne znachennia ekspresii markeriv biolohichnykh vlastyvostei tkanyn pry dysplastychnykh ta neoplastychnykh protsesakh shyiky matky. Medychni perspektyvy. X; 4: 8-16.
Sukhanova AA. (1999). Suchasni pohliady na rol infektsiinoho faktora u vynyknenni ta rozvytku dysplazii epiteliiu shyiky matky. Visnyk asotsiatsii akusheriv-hinekolohiv Ukrainy. 2: 9-14.
Svintsitskyi VS, Pryimak VV, Renkas OP. (2020). Suchasni pidkhody do diahnostyky ta likuvannia raku shyiky matky. Ukr. med. zhurnal. 2: 1-7.
Tatarchuk TF, Silina NK. (2011). Suchasna taktyka vedennia patsiientok iz VPL-asotsiiovanymy neoplazyiamy. Osnovni rekomendatsii EUROGIN 2011. Hinekolohichna endokrynolohiia. 1: 78-80.
Ukrainskyi natsionalnyi konsensus shchodo obstezhennia ta likuvannia zhinok pislia prokhodzhennia pervynnoho tservikalnoho skryninhu. (2022).
Voloshyna NM, Kuznietsova TP, Pauk OP ta insh. (2011). Likuvannia zakhvoriuvan shyiky matky, shcho asotsiiuiutsia z papilomavirusnoiu infektsiieiu u patsiientok molodoho viku. Tavriiskyi medyko-biolohichnyi visnyk. 3; 2(55): 56-60.
Voloshyna NM, Zvantseva ED. (2017). The ways of reducing diagnostic and therapeutic aggression of the patients with HPV-infection in reproductive age. Health of woman. 9(125): 51-58. https://doi.org/10.15574/HW.2017.125.51
Vorobiova LI, Lihirda NF. (2010). Porivniannia terapevtychnoi efektyvnosti zastosuvannia riznykh likarskykh form preparatu alfa-2-interferonu u khvorykh na TsIN I ta TsIN II. Zdorovia zhinky. 5(51): 231-236.
WHO. (2014). Guidelines for Treatment of Cervical Intraepithelial Neoplasia 2-3 and Adenocarcinoma in situ: Cryotherapy, Large Loop Excision of the Transformation Zone, and Cold Knife Conization. Geneva: World Health Organization.
Zakhartseva LM, Manzhura YeP, Vakulenko HV. ta in. (2011). Hiperekspresiia bilka r16 v epitelialnykh klitynakh shyiky matky ta yoho znachennia v otsintsi ryzyku formuvannia raku. Zdorovia zhinky. 4(57): 253-256.
Zaporozhan VM, Kaminskyi VV, Svyntsytskyi VS et al. (2017). National consensus on the management of patients with cervical intraepithelial neoplasia caused by papillomavirus infection. Health of woman. 7(123): 16-24.
Zaporozhan VM, Tatarchuk TF, Dubinina VH ta insh. (2013). Peredpukhlynna patolohiia shyiky matky: obsiah kompetentsii likaria-hinekoloha. Reproduktyvna endokrynolohiia. 7: 7-15.
Zhuk SI, Koshmerynska OM, Taran OO. (2012). Tservikalna intraepitelialna neoplaziia - aktualna problema sohodennia (ohliad literatury). Neonatolohiia, khirurhiia ta perynatalna medytsyna. 4(6): 207-213.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Ukrainian Journal Health of Woman
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
